AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32588968 — intervention group
Group type: EXPERIMENTAL
Intervention: More than 2 vessel entries with large bore sheaths
Number of subjects: 878
Study 32588968 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 878
Study 32588968 — intervention group
Group type: EXPERIMENTAL
Intervention: Two vessel entries with large bore sheaths
Number of subjects: 878
Study 32588968 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 878
Study 32588968 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 878
Study 32588968 — intervention group
Group type: EXPERIMENTAL
Intervention: Vessel wall calcification at puncture site
Number of subjects: 878
Study 33374694 — intervention group
Group type: EXPERIMENTAL
Intervention: Sea salt-based mouthwash containing xylitol and lysozyme
Number of subjects: 0
Study 34224342 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-impact dance intervention (LG)
Number of subjects: 0
Study 34224342 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study 33740394 — intervention group
Group type: EXPERIMENTAL
Intervention: Valganciclovir 900 mg daily
Number of subjects: 31
Study 33740394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 33740394 — intervention group
Group type: EXPERIMENTAL
Intervention: Valganciclovir
Number of subjects: 31
Study 35834252 — intervention group
Group type: EXPERIMENTAL
Intervention: mAb treatment (casirivimab-imdevimab or sotrovimab)
Number of subjects: 3069
Study 35834252 — intervention group
Group type: EXPERIMENTAL
Intervention: casirivimab-imdevimab
Number of subjects: 3069
Study 35834252 — intervention group
Group type: EXPERIMENTAL
Intervention: sotrovimab
Number of subjects: 3069
Study 33046611 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 473
Study 33046611 — intervention group
Group type: EXPERIMENTAL
Intervention: White matter lesions (WML) severity
Number of subjects: 473
Study 33046611 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of treatment allocation and WML severity
Number of subjects: 473
Study 33403334 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoniti A1 (#25) single file
Number of subjects: 105
Study 33403334 — intervention group
Group type: EXPERIMENTAL
Intervention: RaCe #25/.06 single file
Number of subjects: 105
Study 33403334 — intervention group
Group type: EXPERIMENTAL
Intervention: Mtwo #25/.06 single file
Number of subjects: 105
Study 33403334 — intervention group
Group type: EXPERIMENTAL
Intervention: Easy RaCe
Number of subjects: 105
Study 33403334 — intervention group
Group type: EXPERIMENTAL
Intervention: Mtwo multifile
Number of subjects: 105
Study 35896211 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral imatinib
Number of subjects: 385
Study 35896211 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 385
Study 33736663 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy availability (EA) measured at 29.5 kcal/kg FFM/day
Number of subjects: 12
Study 33736663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive restraint (≥13)
Number of subjects: 12
Study 33736663 — intervention group
Group type: COMPARATOR
Intervention: Performance tests (endurance, agility, explosive strength)
Number of subjects: 12
Study 33736663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive restraint
Number of subjects: 12
Study 32185203 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-coated implants
Number of subjects: 52
Study 32185203 — intervention group
Group type: COMPARATOR
Intervention: non-HA-coated implants
Number of subjects: 52
Study 34269640 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief group transdiagnostic psychotherapy (Unified Protocol)
Number of subjects: 105
Study 34269640 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (medication)
Number of subjects: 105
Study 34090368 — intervention group
Group type: EXPERIMENTAL
Intervention: EDDIE program (multi-component intervention)
Number of subjects: 12
Study 616357430 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher MOSSS‐6 scores in men without BPH at baseline
Number of subjects: 2588
Study 616357430 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher MOSSS‐6 scores in men with BPH at baseline
Number of subjects: 2588
Study 36056389 — intervention group
Group type: EXPERIMENTAL
Intervention: CBL-PBL teaching methods
Number of subjects: 4
Study 36056389 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 4
Study 34912506 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mL/day low-fat milk
Number of subjects: 60
Study 34912506 — intervention group
Group type: COMPARATOR
Intervention: 30 g/day pistachio
Number of subjects: 60
Study 35230600 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervisor Audit and Feedback (SAF) intervention
Number of subjects: 60
Study 35230600 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational coding system
Number of subjects: 60
Study 33131328 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise with an arm crank ergometer (15 sessions, 30 minutes/day) at an intensity of 64% to 76% of maximum heart rate, in addition to conventional inpatient rehabilitation
Number of subjects: 40
Study 33131328 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise with an arm crank ergometer
Number of subjects: 40
Study 33131328 — intervention group
Group type: COMPARATOR
Intervention: Conventional inpatient rehabilitation
Number of subjects: 40
Study 33741297 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin (3 days preoperatively)
Number of subjects: 100
Study 33741297 — intervention group
Group type: COMPARATOR
Intervention: Control (no silodosin premedication)
Number of subjects: 100
Study 32066608 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous needle electrolysis combined with eccentric exercise
Number of subjects: 57
Study 32066608 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling combined with eccentric exercise
Number of subjects: 57
Study 32066608 — intervention group
Group type: COMPARATOR
Intervention: Placebo needling combined with eccentric exercise
Number of subjects: 57
Study 34229299 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentially expressed genes (DEGs) identified in bone metastatic CRPC tumors
Number of subjects: 0
Study 34229299 — intervention group
Group type: EXPERIMENTAL
Intervention: Core genes involved in regulation of extracellular matrix receptor interaction and chemotactic activity
Number of subjects: 0
Study 34229299 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune infiltration analysis of CD4+ T cells
Number of subjects: 0
Study 35098820 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose amoxicillin-proton pump inhibitor dual therapy (20 mg esomeprazole four times daily and 750 mg amoxicillin four times daily for 14 days)
Number of subjects: 971
Study 35098820 — intervention group
Group type: COMPARATOR
Intervention: Bismuth-containing quadruple therapy (220 mg bismuth potassium citrate twice daily, 20 mg esomeprazole twice daily, 1000 mg amoxicillin twice daily, and 250 mg clarithromycin capsule twice daily for 14 days)
Number of subjects: 971
Study 35098820 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose amoxicillin-proton pump inhibitor dual therapy
Number of subjects: 971
Study 33421972 — intervention group
Group type: COMPARATOR
Intervention: Simulator training (Group 1)
Number of subjects: 34
Study 33421972 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadaver training (Group 2)
Number of subjects: 34
Study 33902701 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided online cognitive behavioral therapy for insomnia (i-Sleep)
Number of subjects: 70
Study 33902701 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 70
Study 33272333 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 international units) administered daily for 5 days
Number of subjects: 150
Study 33272333 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 international units) administered every other day for 5 days
Number of subjects: 150
Study 33272333 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 international units) administered as a single dose
Number of subjects: 150
Study 33272333 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 150
Study 33272333 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin effects on resting-state functional connectivity
Number of subjects: 150
Study 33837458 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression therapy (IPCT) with compression garment (CG) for 45 min, 3 times a week, for 4 weeks.
Number of subjects: 43
Study 33837458 — intervention group
Group type: COMPARATOR
Intervention: Compression garment (CG) for 24 h, through 4 weeks.
Number of subjects: 43
Study 35229752 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinsing (CMR) with 6.6% maltodextrin
Number of subjects: 13
Study 35229752 — intervention group
Group type: COMPARATOR
Intervention: Mineral water (control)
Number of subjects: 13
Study 35229752 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinsing (CMR)
Number of subjects: 13
Study 36327426 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab plus chemotherapy (D + CT)
Number of subjects: 1013
Study 36327426 — intervention group
Group type: EXPERIMENTAL
Intervention: Tremelimumab plus durvalumab and chemotherapy (T + D + CT)
Number of subjects: 1013
Study 36327426 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (CT)
Number of subjects: 1013
Study 33602211 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) scrubbing (test group 1)
Number of subjects: 30
Study 33602211 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic cleaning with CHX solution, acetone, and ethyl alcohol (test group 2)
Number of subjects: 30
Study 33602211 — intervention group
Group type: COMPARATOR
Intervention: Steam cleaning (control group)
Number of subjects: 30
Study 32211803 — intervention group
Group type: EXPERIMENTAL
Intervention: HFCM containing 6 g spice blend
Number of subjects: 12
Study 32211803 — intervention group
Group type: EXPERIMENTAL
Intervention: HFCM containing 2 g spice blend
Number of subjects: 12
Study 32211803 — intervention group
Group type: COMPARATOR
Intervention: HFCM with 0 g spice blend
Number of subjects: 12
Study 32211803 — intervention group
Group type: COMPARATOR
Intervention: HFCM
Number of subjects: 12
Study 35535151 — intervention group
Group type: EXPERIMENTAL
Intervention: Qibin Tongbian decoction
Number of subjects: 62
Study 34476776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac shock wave therapy (CSWT)
Number of subjects: 30
Study 34476776 — intervention group
Group type: COMPARATOR
Intervention: Control (pseudo-treatment)
Number of subjects: 30
Study 33852655 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferomedial wall orbital decompression (IM-OD)
Number of subjects: 42
Study 33852655 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced medial plus lateral wall orbital decompression (ML-OD)
Number of subjects: 42
Study 35123497 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor light visible from outside the hut
Number of subjects: 300
Study 35123497 — intervention group
Group type: COMPARATOR
Intervention: Closed eaves huts
Number of subjects: 300
Study 35123497 — intervention group
Group type: COMPARATOR
Intervention: Well-ventilated huts
Number of subjects: 300
Study 34478870 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) consisting of eight weekly therapist-led, two-hour group sessions, and home practice (≥30 min/day, 6 days/week) during the 12-month study.
Number of subjects: 766
Study 34478870 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Therapy (MBT) consisting of eight weekly therapist-led, two-hour group sessions, and home practice (≥30 min/day, 6 days/week) during the 12-month study.
Number of subjects: 766
Study 34478870 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 766
Study 34478870 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness-Based Therapy (MBT)
Number of subjects: 766
Study 33398614 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) - transdermal: 980 nm, 200 mW, continuous, average energy fluency of 6 J/cm2 and intravenous: 405 nm, 1.5 mW, continuous for 30 min, applied before and after surgery for 6 days.
Number of subjects: 192
Study 33398614 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 192
Study 33398614 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment only
Number of subjects: 192
Study 35882620 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant durvalumab with standard chemo/radiation followed by 1 year of consolidative durvalumab
Number of subjects: 0
Study 35882620 — intervention group
Group type: COMPARATOR
Intervention: Standard chemo/radiation followed by 1 year of consolidative durvalumab
Number of subjects: 0
Study 34753431 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral training (4 sessions of individual counseling)
Number of subjects: 92
Study 34753431 — intervention group
Group type: COMPARATOR
Intervention: Routine pregnancy visits (control group)
Number of subjects: 92
Study 32868311 — intervention group
Group type: COMPARATOR
Intervention: High carbohydrate + low GI (Cg)
Number of subjects: 163
Study 32868311 — intervention group
Group type: COMPARATOR
Intervention: Low carbohydrate + high GI (cG)
Number of subjects: 163
Study 32868311 — intervention group
Group type: COMPARATOR
Intervention: Low carbohydrate + low GI (cg)
Number of subjects: 163
Study 33970869 — intervention group
Group type: EXPERIMENTAL
Intervention: Norgestrel 75 mcg taken daily
Number of subjects: 52
Study 33970869 — intervention group
Group type: EXPERIMENTAL
Intervention: Norgestrel 75 mcg taken 6 hours late
Number of subjects: 52
Study 33970869 — intervention group
Group type: EXPERIMENTAL
Intervention: Norgestrel 75 mcg missed pill
Number of subjects: 52
Study 32083653 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre-optic confocal microscopy (FCM) using fluorescein sodium dye
Number of subjects: 6
Study 35901043 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified version of the Respecting Choices' advance care planning programme
Number of subjects: 28
Study 33823967 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Responsible Vendor Training (RMV)
Number of subjects: 175
Study 33823967 — intervention group
Group type: COMPARATOR
Intervention: Usual and customary training (Control)
Number of subjects: 175
Study 33823967 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Responsible Vendor Training (RMV) in Washington State
Number of subjects: 175
Study 33823967 — intervention group
Group type: COMPARATOR
Intervention: Usual and customary training (Control) in Washington State
Number of subjects: 175
Study 33823967 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Responsible Vendor Training (RMV) in Colorado
Number of subjects: 175
Study 33823967 — intervention group
Group type: COMPARATOR
Intervention: Usual and customary training (Control) in Colorado
Number of subjects: 175
Study 36855010 — intervention group
Group type: EXPERIMENTAL
Intervention: MLE-based blend (2-g blend of 250 mg MLE, 1.75 g fiber, 0.75 μg vitamin D3, 75 μg chromium)
Number of subjects: 30
Study 36855010 — intervention group
Group type: COMPARATOR
Intervention: Blend without MLE (control)
Number of subjects: 30
Study 36855010 — intervention group
Group type: EXPERIMENTAL
Intervention: MLE-based blend
Number of subjects: 30
Study 33074192 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic stimulation (STN-DBS)
Number of subjects: 159
Study 33074192 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care medical therapy (MED)
Number of subjects: 159
Study 34925217 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) with conventional therapy
Number of subjects: 44
Study 34925217 — intervention group
Group type: COMPARATOR
Intervention: Placebo electrical stimulation (NMESsham) with conventional therapy
Number of subjects: 44
Study 34324504 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt emphasizing government efforts to ensure data privacy
Number of subjects: 23000
Study 34324504 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 23000
Study 32318813 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT + BFR
Number of subjects: 15
Study 32318813 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR
Number of subjects: 15
Study 32318813 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study 36441678 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (2-hour session in a one-day TB educational intervention course)
Number of subjects: 146
Study 36441678 — intervention group
Group type: COMPARATOR
Intervention: Control group (received the same educational materials after the RCT)
Number of subjects: 146
Study 33886568 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg oxazepam
Number of subjects: 33
Study 33886568 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 33886568 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal task
Number of subjects: 33
Study 33458939 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy with completion of frequency volume charts regularly
Number of subjects: 100
Study 33458939 — intervention group
Group type: COMPARATOR
Intervention: Frequency volume charts regularly alone
Number of subjects: 100
Study 33458939 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy with completion of frequency volume charts regularly (after excluding 6 patients with <50% achievement)
Number of subjects: 100
Study 33458939 — intervention group
Group type: COMPARATOR
Intervention: Frequency volume charts regularly alone (after excluding 6 patients with <50% achievement)
Number of subjects: 100
Study 32828135 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) plus standard care
Number of subjects: 194
Study 32828135 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 194
Study 33369223 — intervention group
Group type: EXPERIMENTAL
Intervention: NTI-tss device
Number of subjects: 10
Study 33369223 — intervention group
Group type: COMPARATOR
Intervention: Michigan splint
Number of subjects: 10
Study 34919827 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (PORT) at a dose of 54 Gy in 27 or 30 daily fractions, on five consecutive days a week.
Number of subjects: 501
Study 34919827 — intervention group
Group type: COMPARATOR
Intervention: No postoperative radiotherapy (control group).
Number of subjects: 501
Study 34919827 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (PORT)
Number of subjects: 501
Study 34170904 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated package of continuum of care (CoC) interventions including CoC card, CoC orientation for health workers, and 24-hour stay at a health facility or home visit within 48 hours after delivery.
Number of subjects: 2970
Study 34170904 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated package of continuum of care (CoC) interventions.
Number of subjects: 2970
Study 34170904 — intervention group
Group type: COMPARATOR
Intervention: Control arm (routine services only).
Number of subjects: 2970
Study 33132658 — intervention group
Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CC)
Number of subjects: 331
Study 33132658 — intervention group
Group type: COMPARATOR
Intervention: Regular colonoscopy (RC)
Number of subjects: 331
Study 33132658 — intervention group
Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CC) in patients with constipation
Number of subjects: 331
Study 33132658 — intervention group
Group type: COMPARATOR
Intervention: Regular colonoscopy (RC) in patients with constipation
Number of subjects: 331
Study 33132658 — intervention group
Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CC) in ulcerative colitis patients
Number of subjects: 331
Study 33132658 — intervention group
Group type: COMPARATOR
Intervention: Regular colonoscopy (RC) in ulcerative colitis patients
Number of subjects: 331
Study 33132658 — intervention group
Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CC) during unsedated colonoscopy
Number of subjects: 331
Study 33132658 — intervention group
Group type: COMPARATOR
Intervention: Regular colonoscopy (RC) during unsedated colonoscopy
Number of subjects: 331
Study 36265810 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 112
Study 36265810 — intervention group
Group type: COMPARATOR
Intervention: Standard American diet
Number of subjects: 112
Study 33870426 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral feeding
Number of subjects: 15
Study 33870426 — intervention group
Group type: COMPARATOR
Intervention: G-tube feeding
Number of subjects: 15
Study 33870426 — intervention group
Group type: EXPERIMENTAL
Intervention: RYGB surgery
Number of subjects: 15
Study 32416780 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus platinum-based chemotherapy (group A)
Number of subjects: 1213
Study 32416780 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus platinum-based chemotherapy (group C)
Number of subjects: 1213
Study 32416780 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab monotherapy (group B)
Number of subjects: 1213
Study 35660486 — intervention group
Group type: EXPERIMENTAL
Intervention: PePS plus standard care
Number of subjects: 0
Study 35660486 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 34818575 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (100 mg/kg body weight/day)
Number of subjects: 40
Study 34818575 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusions
Number of subjects: 40
Study 32316758 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training programme (Training Group, n=50)
Number of subjects: 100
Study 32316758 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation procedures (Control Group, n=50)
Number of subjects: 100
Study 35345521 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 155
Study 35345521 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) model
Number of subjects: 155